59% of US teens ages 13-17 say they have used ChatGPT, meaning a majority of the next generation of consumers is already turning to AI chatbots, according to a December report from Pew Research Center.
On today’s podcast episode, we discuss how social platforms became such an important touchpoint for retail, what retailers have done to make social commerce feel like real retail, how creators are evolving from marketing vehicles into platform storefronts for brands, and more. Listen to the discussion with Vice President of Content and host Suzy Davidkhanian, and Senior Analysts Carina Lamb and Minda Smiley.
The world’s biggest You-Tuber pioneers influencer-branded financial products
TD Bank is pushing the human touch as it spends heavily on technology.
Crypto is increasingly mainstream, but community banks could be playing with fire.
More than half (54%) of TikTok users ages 25-44 have gathered more information about a company or product after hearing about it on the platform, according to a December report from Edison Research.
2025 beat expectations, but December softness hints at mounting household strain.
CEO Michael Fiddelke is moving swiftly to spark growth after 12 quarters of sluggish sales.
Early ChatGPT ads favor learning over ROI; high CPMs and limited measurement skew participation toward brands buying influence and insight.
After a bruising Q3, Fiserv’s new strategies show a path forward.
Bilt customer received Wells Autograph Visa regardless of enrollment.
Shoppers using BNPL for essentials versus discretionary spending are displaying different levels of resiliency.
Hasbro shows the upside of franchise fit and timing as industry growth slows.
As economic headwinds leave grocery shoppers hunting for deals and discounts, consumer behaviors have already demonstrably shifted.
Henrique Braun wants faster, market-level launches to unlock new beverage growth.
Novo’s lawsuit and regulator warnings signal a crackdown on compounded GLP-1s across telehealth.
Aetna is finally finding its footing, managing medical costs more effectively, even as industry-wide pressures remain.
Its recent Pfizer and TrumpRx partnerships show how pharma companies are betting on D2C distribution and consumer-facing pricing.
Big linear TV won’t wow all viewers, but the massive reach can still drive research, provider talks, and care.